G Medical Innovations Holdings Ltd (ASX:GMV) CEO Yacov Geva sits down with Proactive Investors' Christine Corrado in New York to update investors on the mobile and e-health company's move to list on the Nasdaq.
Geva says the company, which specializes in software and devices that aim to reduce inefficiencies in health care delivery, will remain listed on the Australian Stock Exchange, but will begin trading on the major US exchange in early 2019.
G Medical’s key product, Prizma, is a smartphone case that transforms any smartphone into a medical monitoring device.
